Data availability
All data could be obtained from Dr Atakan Turgutkaya upon request.
References
Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM et al (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127(20):2391–2405. https://doi.org/10.1182/blood-2016-03-643544
Raedler LA (2014) Diagnosis and management of polycythemia vera. Am Health Drug Benefits. 7(73):S36–S47
Acknowledgements
We thank Dr İbrahim Halil Erdoğdu from Molecular Pathology Department for obtaining molecular results.
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Consent for publication
The patient has given consent for publication.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Turgutkaya, A., Bolaman, A.Z. & Yavaşoğlu, İ. A Potential Novel Entity for Polycythemia Vera: JAK2 Exon 24 Mutation. Indian J Hematol Blood Transfus 39, 710–711 (2023). https://doi.org/10.1007/s12288-023-01663-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-023-01663-0